Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TALIGLUCERASE ALFA Cause Incorrect dose administered? 14 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Incorrect dose administered have been filed in association with TALIGLUCERASE ALFA (ELELYSO). This represents 3.1% of all adverse event reports for TALIGLUCERASE ALFA.

14
Reports of Incorrect dose administered with TALIGLUCERASE ALFA
3.1%
of all TALIGLUCERASE ALFA reports
1
Deaths
6
Hospitalizations

How Dangerous Is Incorrect dose administered From TALIGLUCERASE ALFA?

Of the 14 reports, 1 (7.1%) resulted in death, 6 (42.9%) required hospitalization.

Is Incorrect dose administered Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TALIGLUCERASE ALFA. However, 14 reports have been filed with the FAERS database.

What Other Side Effects Does TALIGLUCERASE ALFA Cause?

Fatigue (59) Arthralgia (43) Off label use (43) Pyrexia (40) Malaise (39) Pain (38) Inappropriate schedule of product administration (37) Pain in extremity (37) Headache (36) Nausea (33)

What Other Drugs Cause Incorrect dose administered?

TIRZEPATIDE (23,301) ADALIMUMAB (14,000) DUPILUMAB (9,907) RANITIDINE (9,337) INSULIN LISPRO (8,318) ACETAMINOPHEN (5,316) DULAGLUTIDE (5,207) SECUKINUMAB (4,524) INSULIN GLARGINE (3,070) SOMATROPIN (2,772)

Which TALIGLUCERASE ALFA Alternatives Have Lower Incorrect dose administered Risk?

TALIGLUCERASE ALFA vs TALIMOGENE LAHERPAREPVEC TALIGLUCERASE ALFA vs TALQUETAMAB TALIGLUCERASE ALFA vs TALQUETAMAB-TGVS TALIGLUCERASE ALFA vs TAMIFLU TALIGLUCERASE ALFA vs TAMOXIFEN

Related Pages

TALIGLUCERASE ALFA Full Profile All Incorrect dose administered Reports All Drugs Causing Incorrect dose administered TALIGLUCERASE ALFA Demographics